Crossmark

[Fe-EOB-tCDTA] generates strong contrast in the blood but not in the liver, despite inhibiting cellular [Gd-EOB-DTPA]2- uptake and partial liver excretion

Crossref DOI link: https://doi.org/10.1186/s41747-026-00731-0

Published Online: 2026-05-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ni, Fei

Haeckel, Akvile

Hojjat, Hamidreza

Schannor, Mathias

Traub, Heike

Schellenberger, Eyk https://orcid.org/0000-0003-4096-6865
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (CRC 1340 B08)

Berlin Institute of Health (BIH Spark Track 2)
License Information

Text and Data Mining valid from 2026-05-13

Version of Record valid from 2026-05-13
More Information

Article History

Received: 19 November 2025

Revised: 12 March 2026

Accepted: 16 April 2026

First Online: 13 May 2026

Declarations

:

: Animal experiments were approved by the LAGeSo Berlin (animal project number: G0067/19).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below